Home LiteratureArticle Details
PMID: 20623550 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.

European journal of immunology ·Vol. 40 ·No. 9 ·2010-09-00 ·Pages 2493-505

Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, Gyenes G, Wong D, Klein MB, Saeed S, Benko E, Kovacs C, Kaul R, Ostrowski MA

Abstract

Co-infection of HCV with HIV has been associated with more rapid progression of HCV-related disease. HCV-specific T-cell immune responses, which are essential for disease control, are attenuated in co-infection with HIV. T-cell exhaustion has recently been implicated in the deficient control of chronic viral infections. In the current study, we investigated the role of programmed death-1 (PD-1) and T-cell immunoglobulin and mucin domain-containing molecule-3 (Tim-3) expression in T-cell exhaustion during HCV/HIV co-infection. We show that in HCV/HIV co-infection, both total and HCV-specific T cells co-express Tim-3 and PD-1 in significantly higher frequencies, compared with HCV mono-infection. Co-expression of these two markers on HCV-specific CD8(+) T cells positively correlated with a clinical parameter of liver disease progression. HCV-specific CD8(+) T cells showed greater frequencies of Tim-3/PD-1 co-expression than HIV-specific CD8(+) T cells, which may indicate a greater degree of exhaustion in the former. Blocking Tim-3 or PD-1 pathways restored both HIV- and HCV-specific CD8(+) T-cell expansion in the blood of co-infected individuals. These data demonstrate that co-expression of Tim-3 and PD-1 may play a significant role in HCV-specific T-cell dysfunction, especially in the setting of HIV co-infection.

MeSH Terms
Antibodies, Blocking/pharmacology Antigens, CD/genetics,immunology,metabolism Antigens, Viral/immunology Apoptosis Regulatory Proteins/genetics,immunology,metabolism CD8-Positive T-Lymphocytes/immunology,metabolism,pathology,virology Cell Proliferation/drug effects Cell Separation Cells, Cultured Disease Progression Female Flow Cytometry HIV Infections/complications,immunology,pathology,physiopathology HIV-1/immunology,pathogenicity HLA-A Antigens/immunology,metabolism HLA-A2 Antigen Hepacivirus/immunology,pathogenicity Hepatitis A Virus Cellular Receptor 2 Hepatitis C/complications,immunology,pathology,physiopathology Humans Liver/immunology,pathology,virology Male Membrane Proteins/genetics,immunology,metabolism Programmed Cell Death 1 Receptor
Chemicals
Antibodies, Blocking Antigens, CD Antigens, Viral Apoptosis Regulatory Proteins HAVCR2 protein, human HLA-A Antigens HLA-A*02:01 antigen HLA-A2 Antigen Hepatitis A Virus Cellular Receptor 2 Membrane Proteins PDCD1 protein, human Programmed Cell Death 1 Receptor
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Vali Bahareh
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Jones R Brad
Sakhdari Ali
Sheth Prameet M
Clayton Kiera
Yue Feng-Yun
Gyenes Gabor
Wong David
Klein Marina B
Saeed Sahar
Benko Erika
Kovacs Colin
Kaul Rupert
Ostrowski Mario A
Article Info
Journal
European journal of immunology
Abbr.
Eur J Immunol
ISSN
1521-4141
Published
2010-09-00
Pages
2493-505
Language
English
Region
Germany
NLM ID
1273201
Subset
IM
Grants
Canadian Institutes of Health Research · Canada
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]